A study by Ortiz-Otero et al. used cell proliferation assays to demonstrate that when co-cultured with prostate cancer cells, reactive CAFs, defined as recently activated CAFs, which showed higher expression of α-SMA and FAP compared to differentiated CAFs, better supported tumor proliferation [32]. The gene discussed is ACTA1; the disease is prostate carcinoma.